Vidalia Mayor opposes court order to restructure Concordia Parish Schools
HERZLIYA, Israel and CALGARY, AB , Nov. 26, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to report positive results from a basic safety assessment study, evaluating LPT-CBD administered as a single injection in Göttingen minipigs. The drug was administered in three ascending doses, and the animals were closely monitored over a 28-day period for key safety parameters. These included clinical observations, vital signs, blood parameters, and local injection site reactions. Encouragingly, no adverse events were recorded during the study. All animals exhibited normal weight gain and demonstrated excellent tolerance to the drug, with no local reactions observed at any of the administered dose sites. Minipigs are breeds of miniature domestic pigs which are recognized by the FDA as a robust translational model due to their anatomical, physiological, and biochemical similarities to humans. They provide valuable insights into pharmacokinetics, toxicity, and drug efficacy. "We are thrilled that LPT-CBD once again demonstrates a promising safety profile, particularly in minipigs, which are widely regarded as a strong toxicology model," said Prof. Chezy Barenholz, Chief Scientific Officer of Innocan Pharma. Dr. Eyal Kalo , Innocan's R&D Director, added: "These results are immensely gratifying as they provide strong feasibility for LPT-CBD's safety evaluation, supporting our upcoming regulatory milestones and paving the way for its ultimate approval." LPT-CBD is an innovative injectable liposomal formulation designed for the sustained release of CBD, targeting the treatment of chronic pain. Previous preclinical studies in various animal models have demonstrated prolonged CBD pharmacokinetics, delivering long-term efficacy. About Innocan Pharma: Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve patients' quality of life. This segment involves innovative drug delivery technology: LPT CBD-loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for Chronic Pain Management. In the Consumer Wellness segment, Innocan develops and markets a wide portfolio of innovative and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan carries on business through subsidiary, BI Sky Global Ltd. that focuses on developing advanced targeted online sales. https://innocanpharma.com/ Contact Information: For Innocan Pharma Corporation: Iris Bincovich, CEO +1 5162104025 +972-54-3012842 +442037699377 info@innocanpharma.com NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. Caution Regarding Forward-Looking Information Certain information set forth in this news release, including, without limitation, the Company's plans for human trials of its LPT-CBD platform, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan's control. . The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of production and distribution arrangements. Forward-looking information is subject to various risks and uncertainties that could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: global and local (national) economic, political, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and potential disruption of relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import/export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release. A comprehensive discussion of other risks that impact Innocan can be found in Innocan's public reports and filings which are available under Innocan's profile at www.sedarplus.ca . Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law. Logo: https://mma.prnewswire.com/media/2046271/3968398/Innocan_Pharma_Corporation_Logo.jpg
Is the world more dangerous than ever for travelers? A global risk expert weighs in
The case first gained widespread attention when Yang Niuhua accused Yu Hua of plagiarism and copyright infringement, claiming that he had stolen and published her works without permission. Despite Yu Hua's denial of the allegations and his insistence that there was no wrongdoing on his part, the legal battle between the two has continued to escalate over the years.
In addition to their on-field exploits, Manchester City's experience in handling pressure situations and navigating the rigors of a grueling season have stood them in good stead. The mental toughness and resilience of the players, coupled with Guardiola's tactical astuteness, have been instrumental in Manchester City's quest for the title.Southeastern Louisiana vs. Nicholls State Best Bets, Predictions & Odds – Nov. 21
TJX Companies, Inc . TJX reported better-than-expected earnings for its third quarter on Wednesday . The company reported third-quarter earnings per share of $1.14 (+11%), beating the street view of $1.09. Quarterly sales of $14.06 billion (+6%) beat the analyst consensus estimate of $13.95 billion. TJX Companies reported a 3% increase in consolidated comparable store sales at the high end of the company's plan, driven entirely by higher customer transactions. "I want to specifically highlight our European team for their strong results, which drove the 7% comp increase at our TJX International division," said Ernie Herrman, Chief Executive Officer and President of The TJX Companies. TJX Companies expects fourth-quarter GAAP EPS to be between $1.12 and $1.14, below the consensus estimate of $1.17. For the fourth quarter, the company continues to expect consolidated comparable store sales to be up 2% to 3%. For FY25, the company revised its GAAP EPS forecast to $4.15 – $4.17, slightly above the prior guidance of $4.09 – $4.13 and in line with the consensus of $4.16. For the full year fiscal 2025, the company continues to expect consolidated comparable store sales to be up 3% TJX shares fell 0.5% to trade at $119.20 on Thursday. These analysts made changes to their price targets on TJX following earnings announcement. Deutsche Bank analyst Gabriella Carbone maintained TJX with a Buy and raised the price target from $130 to $131. Evercore ISI Group analyst Michael Binetti maintained TJX with an Outperform rating and raised the price target from $138 to $142. Telsey Advisory Group analyst Dana Telsey maintained the stock with an Outperform rating and maintained a $134 price target. Considering buying TJX stock? Here’s what analysts think: Read This Next: This Palo Alto Networks Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Public awareness and education campaigns are also being conducted to promote safe driving practices and raise awareness about the risks associated with winter weather conditions. Through the dissemination of information and guidelines, the transportation department aims to empower drivers to make informed decisions and take precautions to protect themselves and others on the road.The AP Top 25 men’s college basketball poll is back every week throughout the season! Get the poll delivered straight to your inbox with AP Top 25 Poll Alerts. Sign up here . BALTIMORE (AP) — Marcus Banks had 14 points in UMBC’s 92-69 victory against Morgan State on Wednesday. Banks added six rebounds for the Retrievers (5-4). Bryce Johnson added 11 points while going 4 of 7 (2 for 3 from 3-point range) and also had six assists. Devan Sapp had 10 points and shot 2 of 6 from the field, including 1 for 4 from 3-point range, and went 5 for 6 from the line. The Bears (3-6) were led by Ahmarie Simpkins, who recorded 16 points, 11 rebounds and two steals. Wynston Tabbs added 16 points and two steals for Morgan State. Kiran Oliver had 11 points. ___ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .
The departure of the manager and director comes amid a string of poor performances on the field, with Manchester United struggling to compete at the highest level of the game. The lack of cohesion and direction within the team has been a cause for concern for fans and analysts alike, leading to mounting pressure on the management to make changes.
Tragically, despite the combined efforts of the crew, passengers, and emergency responders on the ground, the passenger could not be saved. The airline released a statement expressing their condolences to the passenger’s family and thanking the crew and passengers for their swift and compassionate response during the crisis.
/Not for distribution to U.S. news wire services or dissemination in the United States / ST. ALBERT, AB , Nov. 26, 2024 /CNW/ - Enterprise Group, Inc. E ETOLF (the " Company " or " Enterprise Group "), a consolidator of services to the energy sector that is focused primarily on specialized equipment rental, announced today that it has entered into an agreement with Canaccord Genuity Corp. and Raymond James Ltd. (the " Co-Lead Underwriters ") as co-lead underwriters on behalf of a syndicate of underwriters (the " Underwriters ") pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, an aggregate of 10,527,000 common shares at a purchase price of C$1.90 per common share for aggregate gross proceeds of approximately C$20.0 million (the " Offering "). The Company has also granted the Underwriters an over-allotment option, exercisable for a period of 30 days from the date of the closing of the Offering, to purchase up to an additional 15% of the aggregate common shares to be sold pursuant to the Offering. The Company intends to use the net proceeds from the Offering for working capital and general corporate purposes. This funding initiative will support the Company's continued expansion plans, enabling it to capitalize on the robust growth opportunities currently in the burgeoning natural gas turbine power sector, while reinforcing its position as the leading player in the space. With robust activity fuelling the current quarter and a strong pipeline of projects supporting future expansion, the Company believes it is well-positioned to continue delivering strong results going forward underscoring its commitment to creating shareholder value while driving sustained, long-term growth. Closing of the Offering is expected to occur on or about December 12, 2024 , or such other date as may be agreed upon by the Company and the Underwriters, subject to customary closing conditions, including required approvals of the Toronto Stock Exchange. The shares to be issued under the Offering will be offered by way of a short form prospectus in each of the Provinces of Canada, except Quebec, and may be offered in the United States on a private placement basis pursuant to an exemption from the registration requirements of the United States Securities Act of 1933 , as amended, and applicable state securities laws, and certain other jurisdictions outside of Canada and the United States. This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933 , as amended (the " U.S. Securities Act "), and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. Persons (as defined in the U.S. Securities Act), absent registration under U.S. federal and state securities laws or an applicable exemption from such U.S. registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. About Enterprise Group, Inc. Enterprise Group, Inc is a consolidator of services including specialized equipment rental to the energy/resource sector. The Company works with particular emphasis on systems and technologies that mitigate, reduce, or eliminate CO2 and Greenhouse Gas emissions for itself and its clients. The Company is well known to local Tier One and international resource companies with operations in Western Canada . More information is available at the Company's website www.enterprisegrp.ca . Corporate filings can be found on www.sedarplus.ca . Forward Looking Information Certain statements contained in this news release constitute forward-looking information. These statements relate to future events or the Company's future performance. The use of any of the words "could", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements in this news release including, without limitation, statements relating to the Offering, anticipated timing for closing of the Offering and the anticipated use of proceeds. Actual future results may differ materially. The Company's Annual Information Form and other documents filed with securities regulatory authorities (accessible through the SEDAR+ website www.sedarplus.ca ) describe the risks, material assumptions and other factors that could influence actual results and which are incorporated herein by reference. The Company disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as may be expressly required by applicable securities laws. SOURCE Enterprise Group, Inc. View original content: http://www.newswire.ca/en/releases/archive/November2024/26/c0809.html © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Eric Trump, the second son of former President Donald Trump, recently made headlines by stating that traditional banking institutions are outdated and that the United States must lead the way in embracing the cryptocurrency revolution. In a speech delivered at a financial conference in New York City, Eric emphasized the importance of developing a clear regulatory roadmap to navigate the rapidly growing digital asset landscape.